top of page

Psilocybin for the Treatment of Cluster Headache

About the study

NCT Trial Number

NCT02981173

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Yale University|Heffter Research Institute|Cluster Headache-Trigeminal Autonomic Cephalalgia (CH-TAC), LLC

noun_date_3237048.png

Trial Start Date

Nov-16

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Cluster Headache

noun_square_138133.png

Accepts healthy volunteers?

No

This study investigates the effects of an oral psilocybin pulse regimen in cluster headache.

Eyes Graffiti

Locations

United States, Connecticut
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516

Contact: Emmanuelle Schindler, MD
203-932-5711 ext 4335
emmanuelle.schindler@yale.edu

Contact: Taylor Flynn, BS
203-932-5711 ext 2557
leigh.flynn@yale.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page